Mycolactone-Mediated Inhibition of Tumor Necrosis Factor Production by Macrophages Infected withMycobacterium ulceransHas Implications for the Control of Infection
- 1 August 2007
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (8) , 3979-3988
- https://doi.org/10.1128/iai.00290-07
Abstract
The pathogenicity of Mycobacterium ulcerans, the agent of Buruli ulcer, depends on the cytotoxic exotoxin mycolactone. Little is known about the immune response to this pathogen. Following the demonstration of an intracellular growth phase in the life cycle of M. ulcerans, we investigated the production of tumor necrosis factor (TNF) induced by intramacrophage bacilli of diverse toxigenesis/virulence, as well as the biological relevance of TNF during M. ulcerans experimental infections. Our data show that murine bone marrow-derived macrophages infected with mycolactone-negative strains of M. ulcerans (nonvirulent) produce high amounts of TNF, while macrophages infected with mycolactone-positive strains of intermediate or high virulence produce intermediate or low amounts of TNF, respectively. These results are in accordance with the finding that TNF receptor P55-deficient (TNF-P55 KO) mice are not more susceptible than wild-type mice to infection by the highly virulent strains but are more susceptible to nonvirulent and intermediately virulent strains, demonstrating that TNF is required to control the proliferation of these strains in animals experimentally infected by M. ulcerans. We also show that mycolactone produced by intramacrophage M. ulcerans bacilli inhibits, in a dose-dependent manner, but does not abrogate, the production of macrophage inflammatory protein 2, which is consistent with the persistent inflammatory responses observed in experimentally infected mice.Keywords
This publication has 116 references indexed in Scilit:
- Evolution of Mycobacterium ulcerans and Other Mycolactone-Producing Mycobacteria from a Common Mycobacterium marinum ProgenitorJournal of Bacteriology, 2007
- Evidence for an Intramacrophage Growth Phase ofMycobacterium ulceransInfection and Immunity, 2007
- Cytokine mRNA Expression inMycobacteriam ulcerans-Infected Human Skin and Correlation with Local Inflammatory ResponseInfection and Immunity, 2006
- Cytokine Responses to Stimulation of Whole Blood from Patients with Buruli Ulcer Disease in GhanaClinical and Vaccine Immunology, 2005
- Identification using LC-MSn of co-metabolites in the biosynthesis of the polyketide toxin mycolactone by a clinical isolate of Mycobacterium ulceransElectronic supplementary information (ESI) available: Experimental procedures and ESI-CID-MS/MS spectra of mycolactone and the five co-metabolites; MS3 spectrum of m/z 661 from the MS/MS of m/z 749; scheme showing the losses of mass 88 (C4H8O2) during the MS/MS of m/z 749 and the MS3 of m/z 661. See http://www.rsc.org/suppdata/cc/b3/b308163j/Chemical Communications, 2003
- Differential release of tumor necrosis factor-α from murine peritoneal macrophages stimulated with virulent and avirulent species of mycobacteriaFEMS Immunology & Medical Microbiology, 1994
- Immunity to Intracellular BacteriaAnnual Review of Immunology, 1993
- Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunityImmunology Letters, 1988
- Immunosuppressive Properties of the Soluble Toxin from Mycobacterium ulceransThe Journal of Infectious Diseases, 1988
- Toxin of Mycobacterium ulcerans. Production and effects in guinea pig skinArchives of Dermatology, 1974